Digoxin NDC 55154-5882

NDC codes

FDA NDC Directory

Product NDC (as listed)55154-5882Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55154-5882Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
55154-5882-0	55154588200	10 BLISTER PACK in 1 BAG (55154-5882-0) / 1 TABLET in 1 BLISTER PACKMarketed from Jun 10, 2009

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Digoxin
Generic name (nonproprietary): digoxin
Active ingredients: Digoxin — 125 ug/1
Dosage form: Tablet
Route: Oral
Labeler: Cardinal Health 107, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077002
Marketing start: Jun 10, 2009
Listing expires: Dec 31, 2027
Other FDA classes: Cardiac Glycosides (Chemical structure)
Identifiers: Product ID 55154-5882_8d12f04d-943f-4e48-8c47-750d270529c8SPL ID 8d12f04d-943f-4e48-8c47-750d270529c8SPL set ID 51925501-ab5b-4e12-a67e-ec2b4b592e83RxCUI 197604UNII 73K4184T59
Pharmacologic class: Cardiac Glycoside

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N455154588200 followed by a unit qualifier and the quantity

Package 55154-5882-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 20, 2026.

Indications (excerpt from the label)

Digoxin Tablets are a cardiac glycoside indicated for: • Treatment of mild to moderate heart failure in adults. ( 1.1 ) • Increasing myocardial contractility in pediatric patients with heart failure. ( 1.2 ) • Control of resting ventricular rate in patients with chronic atrial fibrillation in adults. ( 1.3 ) 1.1 Heart Failure in Adults Digoxin Tablets are indicated for the treatment of mild to moderate heart failure in adults. Digoxin Tablets increase left ventricular ejection fraction and improve heart failure symptoms as evidenced by improved exercise capacity and decreased heart failure-related hospitalizations and emergency care, while having no effect on mortality. Where possible, Digox…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 077002

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077002
Product	Strength	Form · route	Labeler	Product NDC
Digoxin	Digoxin 125 ug/1	TabletOral	NCS HealthCare of KY, LLC dba Vangard Labs	0615-8202
Digoxin	Digoxin 125 ug/1	TabletOral	Major Pharmaceuticals	0904-5921
Digoxin	Digoxin 250 ug/1	TabletOral	Golden State Medical Supply, Inc.	60429-100
Digoxin	Digoxin 250 ug/1	TabletOral	Major Pharmaceuticals	0904-5922
Digoxin	Digoxin 125 ug/1	TabletOral	Hikma Pharmaceuticals USA Inc.	0143-1240
Digoxin	Digoxin 250 ug/1	TabletOral	Hikma Pharmaceuticals USA Inc.	0143-1241